Clinical Trial Update: CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 study of CC-90010 assesses CNS penetration, pharmacokinetics, and pharmacodynamics in progressive/recurrent diffuse astrocytoma, anaplastic astrocytoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Diffuse Astrocytoma
• Glioblastoma

Drugs mentioned

• CC-90010

Snippet

Sponsor: Celgene | Conditions: Astrocytoma, Glioblastoma | Phase 1 | Status: TERMINATED